Results 41 to 50 of about 42,726 (278)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis

Medical Mycology Case Reports, 2018
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in non-cirrhotic patients with diabetes mellitus, neutropenia, or treatment with corticosteroids.
Jon G. Persichino, Argun D. Can, Tam T. Van, Michele N. Matthews, Scott G. Filler   +4 more
doaj   +1 more source

Field validation of a dusting cloth for mycological surveillance of surfaces [PDF]

, 2011
Efficient monitoring of surfaces for spores of filamentous fungi is essential for detecting minor contamination even when air samples test negative for fungi.
Brenier Pinchart, Marie Pierre, Cavarischia, Roberta, Cerquetani, Franco, D'Alessandro, Daniela, Grillot, Renée, Osborn, John Frederik, Vescia, Nicoletta   +6 more
core   +1 more source

Asthma referrals : a key component of asthma management that needs to be addressed [PDF]

, 2017
Peer reviewedPublisher ...
Bergen, David A, Bjermer, Leif, Martinez, Rafael, Price, David   +3 more
core   +1 more source

Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria? [PDF]

, 2016
The definition of pulmonary fungal infections (PFI) according to the EORTC-MSG criteria may lack diagnostic sensitivity due to the possible presentation of PFI with different radiological pictures.
Ascioglu, Chamilos, De Pauw, Duarte, Even, Girmenia, Girmenia, Girmenia, Hachem, Hansell, Legouge, Nucci, Pagano, Pagano, Qin, Sanz, Segal, Sinkó, Subira, Tsitsikas   +19 more
core   +1 more source

Surgery in pulmonary aspergillosis

The Journal of Thoracic and Cardiovascular Surgery, 1975
Pulmonary aspergillosis is a rare disease, most commonly presenting as secondary invasion of pre-existing cavitary disease. In Toronto General Hospital 24 patients have been recognized as having this disorder in the 10 years from 1965 to 1975. The most common presenting symptoms were cough, sputum production, and hemoptysis, with the hemoptysis ...
E.L. Ritcey, F.G. Pearson, R.D. Henderson, J. Deslaurier, N.C. Delarue   +4 more
openaire   +3 more sources

Pulmonary aspergillosis associated with antineutrophil cytoplasmic antibody-positive vasculitis involving skin and peripheral nerves

Journal of the Indian Academy of Geriatrics
Invasive pulmonary aspergillosis is the most common cause of invasive fungal infection. Vasculitis secondary to bacterial, fungal, viral, and parasitic infections is documented in the literature.
Abhijith Rajaram Rao, Mohamed Rishan, Prakruthi Jaladhar, Prabha Adhikari   +3 more
doaj   +1 more source

Navigating Diagnostic Challenges in Pulmonary Aspergillosis: A Case Series Demonstrating the Synergy of Investigation Techniques [PDF]

International Journal of Scientific Research in Dental and Medical Sciences
Aspergillosis encompasses a spectrum of diseases caused by Aspergillus species, with pulmonary aspergillosis being a significant concern due to its increasing incidence and impact on both immunocompromised and immunocompetent individuals.
Anooja Pulimoottil Mani, Anila Jose
doaj   +1 more source

COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment—A Retrospective Study

Journal of Fungi, 2023
Background: The incidence and outcome of pulmonary aspergillosis in coronavirus disease (COVID-19) patients on extracorporeal membrane oxygenation (ECMO) are unknown and have not been fully addressed.
Ali Nuh, Newara Ramadan, Lisa Nwankwo, Jackie Donovan, Brijesh Patel, Anand Shah, Sujal R. Desai, Darius Armstrong-James   +7 more
doaj   +1 more source

Chronic forms of pulmonary aspergillosis [PDF]

Clinical Microbiology and Infection, 2001
Aspergillus is a genus of fungi commonly found in all environments. Remarkably, only a few species cause disease and equally remarkably, those same species cause multiple diseases. In the lung, exposure to the fungus, the immunological status of the individual and the condition of the lung determine the pattern of disease.
David W. Denning
openalex   +4 more sources

Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability‐enhancing strategies

British Journal of Clinical Pharmacology, EarlyView.
Aims The study aims to predict and improve the absorption of tyrosine kinase inhibitors (TKIs) in patients with malabsorption issues, particularly those who have undergone bariatric surgery or are using proton‐pump inhibitors. The research involves 2 main components: the development of an artificial intelligence (AI) model to identify TKIs that are ...
Daan W. Huntjens, Olivier J. M. Béquignon, Stefanie D. Krens, Mark Löwenberg, Martine E. D. Chamuleau, Remco J. Molenaar, Anita M. G. Kramers, Marianne A. Kuijvenhoven, Imke H. Bartelink   +8 more
wiley   +1 more source